Cargando…
High levels of TNFα in patients with COVID-19 refractory to tocilizumab
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980142/ https://www.ncbi.nlm.nih.gov/pubmed/33848711 http://dx.doi.org/10.1016/j.ejca.2021.01.056 |
| _version_ | 1783667392956596224 |
|---|---|
| author | Danlos, F.X. Ackermann, F. Rohmer, J. Roumier, M. Marabelle, A. Michot, J.M. |
| author_facet | Danlos, F.X. Ackermann, F. Rohmer, J. Roumier, M. Marabelle, A. Michot, J.M. |
| author_sort | Danlos, F.X. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7980142 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79801422021-03-23 High levels of TNFα in patients with COVID-19 refractory to tocilizumab Danlos, F.X. Ackermann, F. Rohmer, J. Roumier, M. Marabelle, A. Michot, J.M. Eur J Cancer Letter to the Editor Published by Elsevier Ltd. 2021-05 2021-03-20 /pmc/articles/PMC7980142/ /pubmed/33848711 http://dx.doi.org/10.1016/j.ejca.2021.01.056 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Danlos, F.X. Ackermann, F. Rohmer, J. Roumier, M. Marabelle, A. Michot, J.M. High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title | High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title_full | High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title_fullStr | High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title_full_unstemmed | High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title_short | High levels of TNFα in patients with COVID-19 refractory to tocilizumab |
| title_sort | high levels of tnfα in patients with covid-19 refractory to tocilizumab |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980142/ https://www.ncbi.nlm.nih.gov/pubmed/33848711 http://dx.doi.org/10.1016/j.ejca.2021.01.056 |
| work_keys_str_mv | AT danlosfx highlevelsoftnfainpatientswithcovid19refractorytotocilizumab AT ackermannf highlevelsoftnfainpatientswithcovid19refractorytotocilizumab AT rohmerj highlevelsoftnfainpatientswithcovid19refractorytotocilizumab AT roumierm highlevelsoftnfainpatientswithcovid19refractorytotocilizumab AT marabellea highlevelsoftnfainpatientswithcovid19refractorytotocilizumab AT michotjm highlevelsoftnfainpatientswithcovid19refractorytotocilizumab |